8,282 Shares in Colgate-Palmolive (NYSE:CL) Purchased by Intellectus Partners LLC

Intellectus Partners LLC acquired a new stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,282 shares of the company's stock, valued at approximately $753,000.

Other institutional investors also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $26,000. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive in the 4th quarter worth $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive during the fourth quarter valued at $32,000. Bernard Wealth Management Corp. bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $36,000. Finally, Roxbury Financial LLC purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $43,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded down $3.39 on Wednesday, reaching $90.71. The company's stock had a trading volume of 9,117,586 shares, compared to its average volume of 4,182,153. The company has a 50-day simple moving average of $89.03 and a 200 day simple moving average of $94.99. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a market cap of $73.61 billion, a P/E ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company earned $0.87 earnings per share. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CL shares. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday, January 17th. Finally, Raymond James reiterated an "outperform" rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and a consensus target price of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.